3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Neuroendocrine Tumors
5
Carcinoma, Renal Cell
4
Neoplasm Metastasis
3
Tuberous Sclerosis
2
Triple Negative Breast Neoplasms
2
Recurrence
2
Glioma
2
Endometrial Neoplasms
2
Adenoma, Islet Cell
2
von Hippel-Lindau Disease
1
Vascular Malformations
1
Unilateral Breast Neoplasms
1
Thymus Neoplasms
1
Seizures
1
Sarcoma, Kaposi
1
Sarcoma
1
Nevus
1
Myelodysplastic Syndromes
1
Multiple Endocrine Neoplasia Type 1
1
Metastatic Digestive System Neuroendocrine Tumor G1
1
Meningioma
1
Lymphangioma
1
Liposarcoma
1
Leukemia, Myeloid, Acute
1
Leiomyosarcoma
1
Kidney Neoplasms
1
Hemangioma
1
Hemangioendothelioma
1
Hamartoma Syndrome, Multiple
1
Interventions
Cisplatin
18
Gemcitabine
14
Radiotherapy, Intensity-Modulated
11
Magnetic Resonance Spectroscopy
8
toripalimab
7
Specimen Handling
7
Capecitabine
7
Platinum
5
Drug Therapy
5
1,2-diaminocyclohexaneplatinum II citrate
5
camrelizumab
4
Radiotherapy
4
Nivolumab
4
spartalizumab
3
sintilimab
3
anlotinib
3
Immunoglobulin G
3
Immune Checkpoint Inhibitors
3
Docetaxel
3
Disulfides
3
atezolizumab
2
Radiation
2
Phantoms, Imaging
2
Ipilimumab
2
Carboplatin
2
CTLA-4 Antigen
2
Biopsy
2
Bevacizumab
2
18-O-demethylcervinomycin A2
2
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Nasopharyngeal Carcinoma
×
Everolimus
×
90 days
×
Clear all
No trials found.